LoveMonsterCG
$RGBP $RGBPP Just to give everyone a heads up...
Regen BioPharma's next financial report will be the company's 10-K annual report for the 4th quarter reporting period and FY ending of September 30, 2026. The due date for the 10-K filing will be December 31, 2026. And from my perspective, as long as David Koos keeps the company's financial reporting "current" within SEC standards, there is always still a chance that he can suddenly appear on the scene again with some news of some kind of business transaction that can be beneficial for current shareholders who are still invested and have continued to hold on to their combined RGBP & RGBPP share holdings throughout this "quiet period". There's always a chance folks! And I don't care what anyone says against that notion! Personally, I'm still holding my 15 million shares! Best wishes everyone! 😊🙏🍀
6